相关实验视频
Updated: Jan 15, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
微RNA-223-3p是血小板前凝活性的决定因素
Julia Charlon-Gay1, Séverine Nolli1, Sylvie Dunoyer-Geindre1
1Geneva Platelet Group, Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
微RNA-223-3p (miR-223-3p) 调节血小板的产生和功能. 这项研究发现,miR-223-3p直接向TMEM16F,调节血小板生成和血栓生成.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 心血管研究研究心血管研究
背景情况:
- 微RNAs (miRNAs) 是细胞过程的关键调节者,包括血小板功能.
- 微RNA-223-3p (miR-223-3p) 在血小板中非常丰富,与心血管事件有关,但其确切作用尚不清楚.
研究的目的:
- 为了研究miR-223-3p对血小板反应和产生的影响.
- 阐明miR-223-3p对血小板功能的影响背后的分子机制.
主要方法:
- 在由CD34+造血干细胞衍生的巨核细胞中产生miR-223-3p的功能增加和丧失.
- 用流细胞计进行表面标记分析,血小板生产和反应性评估.
- 量化了支持血小板的血栓生成,并通过光酶试验验证了TMEM16F作为直接的miR-223-3p标.
主要成果:
- 低调 miR-223-3p 降低了血小板的形成和血小板的产生.
- 无论是miR-223-3p的上调还是下调,都会改变血小板的比例.
- 通过miR-223-3p调节TMEM16F基因表达,并确定TMEM16FmRNA为直接目标.
结论:
- miR-223-3p在调节血小板的生成方面发挥着重要作用.
- miR-223-3p通过直接准TMEM16F,影响血小板的产生和反应性.
更多相关视频
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...